Meta Pixel

News and Announcements

A day in the life of private equity

  • Published March 03, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • The world of private equity is all around us and includes brands like Hilton Hotel Group, Cadbury, Schwepps and Lorna Jane.
  • Some of our most beloved brands exist as a result of Private Equity firms investing in the companies and products we use everyday.
  • The Pengana Private Equity Trust will, for the first time in Australia, provide investors with exposure to a globally diversified portfolio of private equity through an ASX listed vehicle.

Private equity is a particularly interesting asset class due to its performance over many years and its potential to deliver investors with diversification benefits when combined with their existing investments.

For the first time in Australia, the Pengana Private Equity Trust will provide Australian retail investors with the opportunity to access an ASX listed portfolio of global private equity investments.

The initial public offer is now open and we would like to invite you to join our keynote speakers who will be travelling around the country to educate investors on the world of private equity, and provide more information on the investment opportunity.

Reserve your ticket for the roadshow here.

Learn more about this offer here.

Register Interest in Pengana Capital

 

DISCLAIMER:

Pengana Investment Management Limited (ABN 69 063 081 612, Australian Financial Services Licence No. 219462) (“Pengana”) will be the issuer of units in the Pengana Private Equity Trust (ARSN 630 923 643) (the “Trust”). A Product Disclosure Statement for the Trust (“PDS”) will be made available on 4 March 2019. The PDS will be obtainable by contacting Pengana on (02) 8524 9900 or from Pengana’s website at pengana.com/PE1. A person who is considering investing in the Trust should obtain the relevant PDS and should consider the PDS carefully and consult with their financial adviser to determine whether the Trust is appropriate for them before deciding whether to invest in, or to continue to hold, units in the Trust.

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now